Tdap vaccine recommendations
Executive Summary
Centers for Disease Control & Prevention's Advisory Committee on Immunization Practices recommends routine Tdap (tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccine adsorbed) vaccination of adolescents ages 11-12 years. Panel also recommends catch-up program for adolescents who have already received Td booster. FDA recently approved two Tdap vaccines: GlaxoSmithKline's Boostrix and Sanofi-Aventis' Adacel (1"The Pink Sheet" June 20, 2005, p. 28)...
You may also be interested in...
Sanofi’s Adacel Tdap Vaccine Receives Broader Approval Than GSK’s Boostrix
Sanofi-Aventis' postmarketing commitments for Adacel include a 16,000-patient epidemiologic safety surveillance study of the tetanus, diphtheria and acellular pertussis vaccine
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.